ArticleMedical physics2026
Development of a GPU-based dose calculation engine for MRI-guided proton therapy.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMagnetic resonance imaging (MRI)-guided proton therapy (MRPT) integrates the superior soft-tissue contrast of MRI with the high dose conformity of proton therapy. Clinical implementation of MRPT requires an efficient and accurate dose calculation engine capable of accounting for the heterogeneous magnetic field effects on proton beams. PURPOSE: This study developed a GPU-based proton and ion dose engine (gPRIDE) for fast and accurate dose calculations in MRPT under realistic clinical configurations.
methodsTo account for magnetic focusing effects, a novel beam profile correction method was developed. Computational efficiency was enhanced through a region-of-interest-based dose calculation, a linear approximation in ray tracing, and hybrid pencil-beam- and voxel-level GPU parallelization. Three-dimensional magnetic field maps with varying magnetic field strengths were used for validation. gPRIDE was validated against Monte Carlo simulations in a water phantom and four patient cases (prostate, liver, lung, and brain) under two beam orientations: beams parallel and perpendicular to the main magnetic field.
resultsgPRIDE achieved gamma passing rates exceeding 99% under the 2 %/2 mm criterion for all cases except the lung case, where pronounced anatomical heterogeneity posed challenges to analytical modeling. Despite this, gPRIDE still achieved a gamma passing rate
conclusionsgPRIDE enables fast and accurate dose computations under realistic three-dimensional magnetic field maps and supports both beam orientations relative to the main magnetic field. The combination of computational efficiency, accuracy, and versatility facilitates its integration into clinical MRPT workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.